The Drug-Induced Respiratory Disease Website

II - Myocardial dysfunction - Heart failure

II.a

Left ventricular dysfunction/failure

1

Evidence level

low

VI - Cardiomyopathy

VI.a

Cardiomyopathy (acute, subacute, chronic)

1

Evidence level

low

X - Pulmonary edema

X.a

Pulmonary edema, cardiogenic

1

Evidence level

low

XII - Pericardial involvement

XII.b

Pericardial effusion (w/wo tamponade)

1

Evidence level

low

XII.r

Chylous pericardial effusion (w/wo tamponade)

1

Evidence level

low

XIV - Pleural involvement

XIV.a

Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)

1

Evidence level

low

XVI - Hemorrhage - Bleeding - Hematoma(s)

XVI.e

Alveolar hemorrhage (AH), diffuse AH (DAH)

1

Evidence level

low

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

1

Evidence level

low

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)

2

Evidence level

possible

XXIV.b

Pneumonitis (ILD), acute and/or severe (may cause ARDS)

1

Evidence level

low

XXIV.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

1

Evidence level

low